|1.||Romano, A: 3 articles (09/2010 - 01/2007)|
|2.||Gaeta, F: 3 articles (09/2010 - 01/2007)|
|3.||Greenberger, Paul A: 2 articles (05/2012 - 02/2006)|
|4.||Caruso, C: 2 articles (09/2010 - 01/2007)|
|5.||Bousquet, P J: 2 articles (09/2010 - 01/2007)|
|6.||Demoly, P: 2 articles (02/2009 - 01/2007)|
|7.||Viola, M: 2 articles (02/2009 - 01/2007)|
|8.||Paradis, Jean: 1 article (07/2014)|
|9.||Bégin, Philippe: 1 article (07/2014)|
|10.||Picard, Matthieu: 1 article (07/2014)|
02/01/2009 - "The fact that both Hollister-Stier and Allergopharma ceased the production of penicilloyl-polylysine (PPL) and minor determinant mixture (MDM) in 2004 is severely hampering the diagnosis of beta-lactam hypersensitivity and may produce negative consequences. "
01/01/2007 - "Skin testing with penicilloyl polylysine (PPL) and minor determinant mixture (MDM) represents the first-line method for diagnosing beta-lactam hypersensitivity. "
05/01/1991 - "Skin tests with benzyl-penicilloyl polylysine (BPO), minor determinant mixture, and the drug responsible for the previous allergic reaction were positive for 26%, 53%, and 79% of the patients, respectively. "
07/01/2014 - "The absence of commercially available penicilloyl-polylysine (PPL) for most of the last decade severely hampered the practice of penicillin allergy evaluation because skin testing without PPL is reported to have a poor negative predictive value (NPV). "
09/01/2010 - "The contribution of skin testing with penicilloyl-polylysine (PPL) and the minor determinant mixture (MDM) to the diagnosis of hypersensitivity reactions to penicillins differs greatly according to the type of reaction: immediate (occurring within 1 h after the last drug administration) or nonimmediate (occurring more than 1 h after the last drug administration). "
|2.||Anaphylaxis (Anaphylactic Shock)
05/01/1976 - "[Diagnostic significance of the penicilloyl-polylysine test in the light of a case of an anaphylactic shock]."
05/01/2012 - "In patients with a history of penicillin allergy, skin testing helps clarify the current level of risk for anaphylaxis by using the major (penicilloyl-polylysine) and minor penicillin determinants where sensitivity is 99%. "
|5.||Delayed Hypersensitivity (Hypersensitivity, Type IV)
05/01/1998 - "We assessed 24 patients with history of delayed hypersensitivity to aminopenicillins using (1) skin test with penicilloyl polylysine, minor determinant mixture, benzylpenicillin, amoxicillin, and ampicillin; (2) patch tests with benzylpenicillin, amoxicillin, and ampicillin; (3) RAST for penicilloyls G and V; and (4) oral challenges with amoxicillin, ampicillin, and penicillin V in 18/24 patients. "
|2.||Penicillin G (Benzylpenicillin)
|5.||Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)
|7.||Penicillin V (Phenoxymethylpenicillin)
|10.||Immunoglobulin E (IgE)